You are here

Generic Neurontin Now Available

MIAMI, Sept. 30 /PRNewswire/ -- For the more than 4 million Neurontin® Capsule prescriptions written in the United States, a low-cost alternative called IVAX Gabapentin Tablets is now available.

IVAX Gabapentin Tablets is the first available FDA-approved generic that contains the same chemical ingredient as Pfizer's Neurontin® Capsules, an epilepsy drug whose U.S. sales reached $2.4 billion in 2003.

IVAX 100 mg, 300 mg and 400 mg Gabapentin Tablets are available through pharmacies nationwide. Neurontin® Capsule prescription holders should ask their health care professionals about switching to IVAX Gabapentin Tablets.

"Neurontin® Capsule prescription holders may save money by switching to IVAX Gabapentin Tablets," said IVAX President and CEO, Dr. Rafick Henein. "The savings are in the form of lower co-payments for the 80 percent or more whose prescriptions could be covered by their health insurance, and even greater savings are possible for those who pay cash because they do not have insurance."

Alfonso Molina, a pharmacist with Walgreens, said, "For more than 20 years, generic pharmaceuticals have been used by millions of people as an effective, affordable alternative to brand-name pharmaceuticals. Generic drugs are strictly regulated by the FDA and deliver the same medication as brand-name pharmaceuticals."

For more information about IVAX Gabapentin Tablets and full prescribing information, visit or call 1-800-327-4114.

IVAX Gabapentin Tablets are manufactured and distributed by Miami-based IVAX Pharmaceuticals, Inc., which discovers, develops, manufactures and markets both branded and brand-equivalent (generic) pharmaceuticals in the United States and abroad.

Neurontin® is a registered trademark of Pfizer, Inc.

Source: IVAX Pharmaceuticals, Inc.

Recent Headlines

One in Five Kids’ Office Visits Results in an Off-Label Rx
Related Settlement Would End Many but Not All Lawsuits
Chronic Kidney Patients With Hyperphosphatemia May Be Another Market for the Drug
Nitrosamine Impurity Also Affects Other Ranitidine Drugs
Mesh Implants, Now Banned by FDA, Work as Well as Hysterectomy
Disrupting Gut Microbiome Could Be Key
Drug Boosts Levels of Natural Endocannabinoids
Judicious Use of Antibiotics May Not Be Enough To Defeat Bacteria That Carry On By Going Into a Dormant State
KRAS Oncogene Is a Problematic Target So Researchers Are Trying Workdarounds